Iyh a strong buy?

**iShares U.S. Healthcare ETF (IYH) is not a strong buy at this time.** Here's why: 1. **Lack of Analyst Coverage**: There are no available analyst average price targets for IYH, which makes it difficult to gauge the consensus opinion among analysts. 2. **Recent Performance**: The ETF has been trading at a 52-week high, indicating strong recent performance. However, this does not necessarily reflect future performance. 3. **Institutional Activity**: There has been significant institutional activity, with multiple investors increasing their stakes in IYH. This could be a positive sign, but it alone does not make a stock a strong buy. 4. **Market Conditions**: The healthcare sector is expected to grow, and IYH offers diversified exposure to it. However, this does not guarantee individual stock performance. 5. **Fundamentals**: The ETF has a market capitalization of $3.64 billion, a PE ratio of 4.91, and a beta of 0.56. These are standard metrics, but they do not definitively indicate whether a stock is a strong buy. In conclusion, while IYH has some positive aspects, the lack of analyst coverage and the absence of a specific target price make it difficult to classify it as a strong buy. Investors should consider other factors and their own investment strategy when making decisions.